Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Daiichi Sankyo
Covington
US Department of Justice
Julphar

Generated: July 22, 2019

DrugPatentWatch Database Preview

Litigation Details for Medicis Pharmaceutical Corporation v. Aurobindo Pharma Ltd. (D. Del. 2010)

Try a free trialSee Plans and Pricing

« Back to Dashboard

Medicis Pharmaceutical Corporation v. Aurobindo Pharma Ltd. (D. Del. 2010)

Docket ➤ Try a Free Trial Date Filed 2010-12-03
Court District Court, D. Delaware Date Terminated 2011-09-14
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand None Referred To
Parties AUROBINDO PHARMA LTD.; AUROBINDO PHARMA USA INC.; MEDICIS PHARMACEUTICAL CORPORATION
Patents 5,908,838; 7,790,705
Attorneys Jack B. Blumenfeld; Karen Jacobs Louden; Richard D. Kirk
Firms Morris, Nichols, Arsht & Tunnell
Link to Docket External link to docket
Small Molecule Drugs cited in Medicis Pharmaceutical Corporation v. Aurobindo Pharma Ltd.
The small molecule drugs covered by the patents cited in this case are ➤ Try a Free Trial and ➤ Try a Free Trial .

Details for Medicis Pharmaceutical Corporation v. Aurobindo Pharma Ltd. (D. Del. 2010)

Date Filed Document No. Description Snippet Link To Document
2011-09-13 10 United States Patent Nos. 5,908,838 (“the ’838 patent”) and 7,790,705 (“the ’705 patent”). WHEREAS, Defendants…United States Patent Nos. 5,908,838 (“the ’838 patent”) and 7,'79(),705 (“the ’705 patent”). 3. Defendants… 25, and 27-34 of the ’838 patent and one or more claims of the ’705 patent under 35 U.S.C. § 271(e)(2… 25, and 27-34 of the ’838 patent and one or more claims of the ’705 patent. WHEREAS, in this Litigation…enjoining Defendants from infringing the ’838 and ’705 patents. WHEREAS, Medicis and Defendants have reached External link to document
2011-09-14 11 Medicis owns United States Patent Nos. 5,908,838 ("the '838 patent") and 7,790,705 ("…infringement of United States Patent Nos. 5,908,838 ("the '838 patent") and 7,790,705 ("…and 27-34 of the '838 patent and one or more claims of the '705 patent under 35 U.S.C. § 271(e)…and 27-34 of the '838 patent and one or more claims of the '705 patent. WHEREAS…quot;the '705 patent"). WHEREAS, Defendants submitted Abbreviated New Drug Application External link to document
2011-09-14 12 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,908,838; 7,790,705. (ntl) (… 14 September 2011 1:10-cv-01050 830 Patent None District Court, D. Delaware External link to document
2010-12-03 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,908,838; 7,790,705. (nms) (… 14 September 2011 1:10-cv-01050 830 Patent None District Court, D. Delaware External link to document
Date Filed Document No. Description Snippet Link To Document

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
AstraZeneca
Boehringer Ingelheim
Moodys
Argus Health
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.